• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.04% Nasdaq Down1.11%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NasdaqGM
    0.83 Up 0.03(3.61%) 3:58PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 512   247   735   356  
    Cost of Revenue -   -   -   -  
    Gross Profit 512   247   735   356  
    Operating Expenses
    Research Development4,342  4,416  4,972  4,545  
    Selling General and Administrative1,468  1,613  1,433  1,386  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (5,298) (5,782) (5,670) (5,575)
    Income from Continuing Operations
    Total Other Income/Expenses Net(377)(125)9  (60)
    Earnings Before Interest And Taxes(5,675)(5,907)(5,661)(5,635)
    Interest Expense -   -   -   -  
    Income Before Tax(5,675)(5,907)(5,661)(5,635)
    Income Tax Expense(763)(1,108)(750)(816)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(4,912)(4,799)(4,911)(4,819)
    Non-recurring Events
    Discontinued Operations -   -  4  7  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (4,912) (4,799) (4,907) (4,812)
    Preferred Stock And Other Adjustments(50)(50)(50)(50)
    Net Income Applicable To Common Shares (4,962) (4,849) (4,957) (4,862)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.